On January 26th,2024 our CSO Satoshi Tamaki will be a featured speaker at the 452nd conference of the Chem-Bio Informatics  (CBI) Society, titled “Creating New Value through Automation – Core Technology × Automation”. In his presentation, “de novo Antibody Drug Screening Using AI Robot-Driven Science”, Tamaki will introduce our AI drug discovery platform, which has successfully identified new antibody drug candidates through AI learning based on biological experiments and the automation of experimental processes for high-throughput data acquisition.

This event will be conducted online and in Japanese. For more information and registration for the seminar, please visit the event page of CBI Society.